Skip to main content

Advertisement

Log in

Long-term outcome after aneurysmal subarachnoid hemorrhage—risks of vascular events, death from cancer and all-cause death

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Smoking and hypertension are risk factors for aneurysmal subarachnoid hemorrhage (aSAH), but also for other cardiovascular diseases and cancer. Few prospective data are available on the very long term risks of vascular diseases and vascular, cancer-related and overall death after aSAH. We determined vascular events and survival status in 1,765 patients with aSAH admitted to our center from 1985 to 2010. Cumulative risks were estimated with survival analysis. We compared risks of vascular, cancer-related and all-cause death with the general population with standardized mortality ratios (SMRs). Incidences of vascular events and death were compared with those after TIA/minor stroke. Conditional on surviving 3 months after aSAH, the risk of death was 8.7 % (95 % CI 7.3–10.1) within 5 years, 17.9 % (16.1–19.9) within 10 years, 29.5 % (27.3–31.8) within 15 years, and 43.6 % (41.2–46.1) within 20 years after SAH. The SMR for all-cause death was 1.8 (1.6–2.1), for vascular death 2.0 (95 % CI 1.6–2.5) and for cancer-related death 1.2 (0.9–1.5; sensitivity analysis 1.4; 95 % CI 1.1–1.8). The increased SMR for all-cause death persevered up to 20 years after aSAH. Compared with TIA/minor stroke patients, the age- and sex-adjusted cumulative incidence on vascular events was lower for aSAH patients [hazard ratio (HR) 0.48; 95 % CI 0.40–0.57); the HR for all-cause death was 0.96 (95 % CI 0.84–1.10). After aSAH, risks of vascular events and death, and probably also that of cancer-related death, are higher than in the general population. Although the long-term risk of vascular events was lower in aSAH patients than in TIA/minor stroke patients, the risk of death was similar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635–642

    Article  PubMed  Google Scholar 

  2. Wermer MJ, Greebe P, Algra A, Rinkel GJ (2005) Incidence of recurrent subarachnoid haemorrhage after clipping for ruptured intracranial aneurysms. Stroke 36:2394–2399

    Article  PubMed  Google Scholar 

  3. Huttunen T, Fraunberg MV, Koivisto T, Ronkainen A, Rinne J, Sankila R, Seppa K, Jaaskelainen JE (2010) Long-term excess mortality of 244 familial and 1,502 sporadic 1 year survivors of aneurysmal subarachnoid haemorrhage compared with a matched eastern Finnish catchment population. Neurosurgery 68:20–27

    Article  Google Scholar 

  4. Molyneux AJ, Kerr RS, Birks J, Ramzi N, Yarnold J, Sneade M, Rischmiller J (2009) Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the international subarachnoid aneurysm trial (ISAT): long-term follow-up. Lancet Neurol 8:427–433

    Article  PubMed Central  PubMed  Google Scholar 

  5. Nieuwkamp DJ, Algra A, Blomqvist P, Adami A, Buskens E, Koffijberg H, Rinkel G (2011) Excess mortality and cardiovascular events in patients surviving subarachnoid haemorrhage: a nationwide study in Sweden. Stroke 42:902–907

    Article  PubMed  Google Scholar 

  6. Nieuwkamp DJ, Vaartjes I, Algra A, Rinkel GJ, Bots ML (2012) Risk of cardiovascular events and death in the life after aneurysmal subarachnoid haemorrhage: a nationwide study. Int J Stroke. doi:10.1111/j.1747-4949.2012.00875.x

  7. Ronkainen A, Niskanen M, Rinne J, Koivisto T, Hernesniemi J, Vapalahti M (2001) Evidence for excess long-term mortality after treated subarachnoid haemorrhage. Stroke 32:2850–2853

    Article  CAS  PubMed  Google Scholar 

  8. Wermer MJ, Greebe P, Algra A, Rinkel GJ (2009) Long-term mortality and vascular event risk after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 80:1399–1401

    Article  CAS  PubMed  Google Scholar 

  9. Korja M, Silventoinen K, Laatikainen T, Jousilahti P, Salomaa V, Kaprio J (2013) Cause-specific mortality of 1-year survivors of subarachnoid haemorrhage. Neurology 80:481–486

    Article  PubMed Central  PubMed  Google Scholar 

  10. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, Anderson CS (2005) Risk factors for subarachnoid haemorrhage: an updated systematic review of epidemiological studies. Stroke 36:2773–2780

    Article  PubMed  Google Scholar 

  11. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V (1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100:1481–1492

    Article  CAS  PubMed  Google Scholar 

  12. Ruigrok YM, Buskens E, Rinkel GJ (2001) Attributable risk of common and rare determinants of subarachnoid haemorrhage. Stroke 32:1173–1175

    Article  CAS  PubMed  Google Scholar 

  13. Huttunen T, Riihinen A, Pukkala E, von und zu, Fraunberg M, Koivisto T, Ronkainen A, Rinne J, Hernesniemi J, Sankila R, Jaaskelainen JE (2012) Increased relative risk of lung cancer in 2,904 patients with saccular intracranial aneurysm disease in eastern Finland. Neuroepidemiology 38:93–99

    Article  PubMed  Google Scholar 

  14. van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, Gorter JW, Algra A (2005) Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet 365:2098–2104

    Article  PubMed  Google Scholar 

  15. The ACROSS Group (2000) Epidemiology of aneurysmal subarachnoid haemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian cooperative research on subarachnoid haemorrhage study (ACROSS). Stroke 31:1843–1850

    Article  Google Scholar 

  16. Rinkel GJ, Algra A (2011) Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 10:349–356

    Article  PubMed  Google Scholar 

  17. Guglielmi G, Vinuela F, Duckwiler G, Dion J, Lylyk P, Berenstein A, Strother C, Graves V, Halbach V, Nichols D (1992) Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. J Neurosurg 77:515–524

    Article  CAS  PubMed  Google Scholar 

  18. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R (2002) International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2,143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267–1274

    Article  PubMed  Google Scholar 

  19. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636–642

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

On behalf of all authors, the corresponding author states that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dennis J. Nieuwkamp.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nieuwkamp, D.J., de Wilde, A., Wermer, M.J.H. et al. Long-term outcome after aneurysmal subarachnoid hemorrhage—risks of vascular events, death from cancer and all-cause death. J Neurol 261, 309–315 (2014). https://doi.org/10.1007/s00415-013-7192-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-7192-8

Keywords

Navigation